Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs
Author(s) -
Pierre Gantner,
Guinevere Q. Lee,
David Rey,
Thibault Mésplède,
Marialuisa Partisani,
Christine Cheneau,
Geneviève Beck-Wirth,
J Faller,
M. Mohseni-Zadeh,
M. Martinot,
Mark A. Wainberg,
Samira FafiKremer
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx475
Subject(s) - dolutegravir , human immunodeficiency virus (hiv) , virology , genetic diversity , biology , genetics , medicine , antiretroviral therapy , environmental health , viral load , population
Better understanding of the dynamics of HIV reservoirs under ART is a critical step to achieve a functional HIV cure. Our objective was to assess the genetic diversity of archived HIV-1 DNA over 48 weeks in blood cells of individuals starting treatment with a dolutegravir-based regimen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom